Filing Details
- Accession Number:
- 0001181431-14-008957
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-24 20:28:45
- Reporting Period:
- 2014-02-20
- Filing Date:
- 2014-02-24
- Accepted Time:
- 2014-02-24 20:28:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
927066 | Davita Healthcare Partners Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1005547 | M John Nehra | C/O Davita Healthcare Partners Inc. 2000 16Th Street Denver CO 80202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-20 | 36,000 | $22.92 | 134,255 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-20 | 12,489 | $66.07 | 121,766 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-02-20 | 30,000 | $65.74 | 91,766 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-21 | 10,000 | $66.05 | 81,766 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Right | Disposition | 2014-02-20 | 36,000 | $0.00 | 36,000 | $22.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-06-15 | 2014-06-15 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price of $65.7368. The range of prices for the sale of these shares was $65.65 - $65.80. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- Represents the weighted average sale price of $66.0472. The range of prices for the sale of these shares was $65.98 - $66.09. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- Stock Appreciation Rights, granted on June 15, 2009 pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 100% on the first anniversary of the grant date.